Aciclovir (Paediatric)
Brand names: Zovirax
Adult dose
Paediatric dose
Dose adjustments
CrCl 25–50: extend interval to every 12 hours; CrCl 10–25: every 24 hours; CrCl <10: 50% dose every 24 hours; ensure adequate hydration in all cases
No dose adjustment required
BNFc: NEONATAL HERPES — 20 mg/kg every 8 hours is a HIGH dose (not 10 mg/kg) — critical distinction; inadequate treatment of neonatal HSV causes death or severe neurodevelopmental impairment. IV must be given over 1 hour (nephrotoxic if given rapidly — crystalluria in renal tubules). Ensure adequate hydration throughout. Oral aciclovir bioavailability is poor (15–30%) — not suitable for serious infections. (or mg/m²)
Clinical pearls
- Neonatal herpes dosing: 20 mg/kg (not 10 mg/kg) every 8 hours — higher dose required because of immature thymidine kinase activity and different pharmacokinetics; confusion between adult and neonatal doses is a patient safety issue
- HSV encephalitis: empirical IV aciclovir must not be delayed pending PCR results — start immediately on clinical suspicion (fever + encephalopathy); CSF HSV PCR can be false-negative in first 24–48 hours
- Hydration critical: aciclovir crystallises in renal tubules when concentrated — give 150–200 mL/hour IV fluids alongside aciclovir infusion in neonates/children; reduce rate in those at risk of fluid overload
- VZV in immunocompromised: chickenpox in immunocompromised children (leukaemia, transplant) — life-threatening; start IV aciclovir immediately, do not wait for hospitalisation
Contraindications
- Hypersensitivity to aciclovir or valaciclovir
Side effects
- Nephrotoxicity (crystalluria — ensure hydration; give over 1 hour)
- Neurotoxicity (agitation, confusion, hallucinations — especially in renal failure)
- Phlebitis (IV)
- Nausea
- Elevated LFTs
- Rash
Interactions
- Probenecid — increases aciclovir levels
- Nephrotoxic drugs — additive nephrotoxicity
- Ciclosporin — additive nephrotoxicity
- Mycophenolate — competitive tubular secretion (increased levels of both)
Monitoring
- Renal function and urine output (daily)
- Hydration status
- Neurotoxicity (agitation, tremor)
- CSF HSV PCR (repeat at day 14–21 for CNS herpes — guide duration)
- Clinical response
Reference: BNF for Children; NICE NG41 (Meningitis); PHE Neonatal Herpes Guidelines; BPSU/BPNG Neonatal Herpes Simplex Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
- PICU Delirium Assessment (pCAM-ICU) · Delirium Assessment
- Vasoactive-Inotropic Score (VIS) · Inotropic Support
- Lund-Browder Chart — TBSA Burn Estimation · Burns
- Glucose Infusion Rate (GIR) Calculator · Glucose Management
- Kocher Criteria for Septic Arthritis · Bone & Joint Infection
- Influenza Severity Score (FluSS) · Influenza